In addition to supporting pharmaceutical and medical device companies in achieving market access and driving product development, Brandwood CKC also provides due diligence services to medical companies seeking to diversify their portfolios, and to investment/business consulting firms seeking to understand the highly regulated/technical challenges and opportunities of new medicine, medical device or diagnostic ventures. These services range from provision of insight into the regulatory and commercialisation environment and predictions as to overall market trends, through to determination of the technical and commercialisation challenges for early phase development.